- BA, Physics: Washington University, St. Louis, MO (2002)
- MS, Physics: Washington University, St. Louis, MO (2004)
- PhD, Experimental Nuclear Physics: Washington University, St. Louis, MO (2008)
- Residency, Medical Physics: Washington University School of Medicine, St. Louis, MO (2011)
Olga Green, PhD is an assistant professor of radiation oncology and Associate Director of the Medical Physics Residency Program. Professor Green joined the faculty in 2011. She earned a PhD in Experimental Nuclear Physics in 2008 from Washington University in St. Louis and completed her residency in medical physics, CAMPEP accredited, at Washington University School of Medicine in 2011. She is certified in Therapeutic Radiological Physics by the American Board of Radiology. Dr. Green’s clinical work and research focuses on magnetic resonance image-guided radiation therapy. She is the lead authorized medical physicist for the first-in-the world MR-IGRT system.
Uulke van der Heide
Uulke van der Heide received his PhD degree (cum laude) in the field of molecular biophysics from the Utrecht University in 1993. He subsequently worked as a post-doc at the physiology departments of the University Medical Center in Utrecht and at the University of Pennsylvania in Philadelphia, US, on the molecular mechanism of motor proteins.
In 1999 he moved to the field of radiation oncology, as a resident medical physicist at the University Medical Center in Utrecht. He got his license in 2003. Between 2003 and 2011 he worked as a medical physicist and researcher in the same department, working on MRI-guided radiotherapy, focussing on prostate cancer. Together with Marco van Vulpen he initiated the phase III FLAME trial for focal boosting of prostate cancer.
In 2011 he moved to the Netherlands Cancer Institute as a medical physicist and group leader, working on MRI-guided radiotherapy. In this capacity he is project leader of the MR-Linac project. His research focusses on quantitative MRI techniques for tumor characterization and response monitoring of radiotherapy. In August 2015 he was appointed professor of imaging technology in radiation oncology at the Leiden University Medical Center
Dr Simon Puttick’s research is centered around the development of advanced therapies for brain cancers guided by medical imaging technologies. His projects include the development of theranostics based on engineered antibodies, the development of MRI and PET imaging acquisition schemes that highlight physiological heterogeneity in brain tumours to predict treatment efficacy, the development of actively triggered drug releasing implants for brain cancers and the development of comparative neuro-oncology trials for more effective translation of promising therapies to the clinic.
Dr Simon Puttick completed his PhD under the supervision of Professor Peter Licence at the University of Nottingham in July 2012. Following his PhD he moved to the Wolfson Brain Imaging Centre at the University of Cambridge as a Research Fellow under the supervision of Professor A. Jennifer Morton where his research was focussed on the development of MRI biomarkers of neural degeneration in Huntingtons disease. He moved to the AIBN in January 2013 as a Research Fellow in Professor Andrew Whittakers group focussed on the development of theranostics for brain cancers. Dr Puttick is currently employed as an AIBN-CSIRO Research Fellow working within Professor Whittakers group and the CSIRO Probing Biosystems Future Science Platform where he leads a program of research focussed on the development of advanced therapies for brain cancers.